Search

everythinglearnresearchcommunity

for

Search:↓

The case shows how hard it is to tell apart Multiple Autoimmune Syndrome from other similar autoimmune conditions, but correct diagnosis is key for treatment to work.

MCTD should be considered in children with recurring muscle issues, lupus-like symptoms, and edema.

The BASP classification is a detailed system for categorizing hair loss in both men and women, but it may be complex for beginners and not fully suitable for grading female hair loss.

A woman with undifferentiated connective tissue disease was diagnosed with renal amyloidosis and carpal tunnel syndrome.

Different hair loss patterns may be linked to varying male hormone levels.

Newborns with the common rash Erythema Toxicum have many active mast cells in their skin, but these cells don't produce the LL-37 peptide.

Activating TLR3 may help produce retinoic acid, important for tissue regeneration.

FUE megasession effectively treats severe hair loss with natural-looking results in one operation.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

The BASP classification is a detailed and accurate way to categorize hair loss in both men and women.

Men with hair loss experience lower quality of life, worsened by factors like age, severity, and treatment history.

Researchers created a fully functional, bioengineered skin system with hair from stem cells that successfully integrated when transplanted into mice.

HFMs can help study hair growth and test potential hair growth drugs.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

The flexible fixed-sequence testing method allows for more effective evaluation of multiple goals in a clinical trial while controlling the risk of false positives.

The document concludes that hair transplantation and gene therapy may be important for future hair loss treatment.

Asian hair loss differs from Europeans; consider individual needs and psychological well-being for treatment.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Manatee whiskers are specially adapted for touch in water.

TrichoScan® is a reliable tool for measuring hair growth, providing quicker and more consistent results than manual methods.

Testosterone therapy can help postmenopausal women with low sexual desire if monitored carefully.

Use 5% minoxidil or oral finasteride for mild-to-moderate hair loss, combine with hair transplant for severe cases.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.

Ganoderma lucidum may help treat enlarged prostate in rats.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Double-stranded RNA causes inflammation in hair follicle cells, which may help understand and treat alopecia areata.